γ-Filamin, also called ABP-L, is a filamin isoform that is specifically expressed in striated muscles, where it is predominantly localized in myofibrillar Z-discs. A minor fraction of the protein shows subsarcolemmal localization. Although γ-filamin has the same overall structure as the two other known isoforms, it is the only isoform that carries a unique insertion in its immunoglobulin (Ig)-like domain 20. Sequencing of the genomic region encoding this part of the molecule shows that this insert is encoded by an extra exon. Transient transfections of the insert-bearing domain in skeletal muscle cells and cardiomyocytes show that this single domain is sufficient for targeting to developing and mature Z-discs. The yeast two-hybrid method was used to identify possible binding partners for the insert-bearing Ig-like domain 20 of γ-filamin. The two Ig-like domains of the recently described α-actinin–binding Z-disc protein myotilin were found to interact directly with this filamin domain, indicating that the amino-terminal end of γ-filamin may be indirectly anchored to α-actinin in the Z-disc via myotilin. Since defects in the myotilin gene were recently reported to cause a form of autosomal dominant limb-girdle muscular dystrophy, our findings provide a further contribution to the molecular understanding of this disease.
Skip Nav Destination
Article navigation
16 October 2000
Article|
October 16 2000
Indications for a Novel Muscular Dystrophy Pathway: γ-Filamin, the Muscle-Specific Filamin Isoform, Interacts with Myotilin
Peter F.M. van der Ven,
Peter F.M. van der Ven
aDepartment of Cell Biology, University of Potsdam, D-14471 Potsdam, Germany
Search for other works by this author on:
Sebastian Wiesner,
Sebastian Wiesner
aDepartment of Cell Biology, University of Potsdam, D-14471 Potsdam, Germany
Search for other works by this author on:
Paula Salmikangas,
Paula Salmikangas
bDepartment of Pathology, Haartman Institute, University of Helsinki, SF-00290 Helsinki, Finland
Search for other works by this author on:
Daniel Auerbach,
Daniel Auerbach
cInstitute of Cell Biology, Swiss Federal Institute of Technology, Hönggerberg, CH-8093 Zürich, Switzerland
Search for other works by this author on:
Mirko Himmel,
Mirko Himmel
aDepartment of Cell Biology, University of Potsdam, D-14471 Potsdam, Germany
Search for other works by this author on:
Stefan Kempa,
Stefan Kempa
aDepartment of Cell Biology, University of Potsdam, D-14471 Potsdam, Germany
Search for other works by this author on:
Katrin Hayeß,
Katrin Hayeß
aDepartment of Cell Biology, University of Potsdam, D-14471 Potsdam, Germany
Search for other works by this author on:
Dirk Pacholsky,
Dirk Pacholsky
aDepartment of Cell Biology, University of Potsdam, D-14471 Potsdam, Germany
Search for other works by this author on:
Anu Taivainen,
Anu Taivainen
bDepartment of Pathology, Haartman Institute, University of Helsinki, SF-00290 Helsinki, Finland
Search for other works by this author on:
Rolf Schröder,
Rolf Schröder
dDepartment of Neurology, University Hospital Bonn, D-53127 Bonn, Germany
Search for other works by this author on:
Olli Carpén,
Olli Carpén
bDepartment of Pathology, Haartman Institute, University of Helsinki, SF-00290 Helsinki, Finland
Search for other works by this author on:
Dieter O. Fürst
Dieter O. Fürst
aDepartment of Cell Biology, University of Potsdam, D-14471 Potsdam, Germany
Search for other works by this author on:
Peter F.M. van der Ven
aDepartment of Cell Biology, University of Potsdam, D-14471 Potsdam, Germany
Sebastian Wiesner
aDepartment of Cell Biology, University of Potsdam, D-14471 Potsdam, Germany
Paula Salmikangas
bDepartment of Pathology, Haartman Institute, University of Helsinki, SF-00290 Helsinki, Finland
Daniel Auerbach
cInstitute of Cell Biology, Swiss Federal Institute of Technology, Hönggerberg, CH-8093 Zürich, Switzerland
Mirko Himmel
aDepartment of Cell Biology, University of Potsdam, D-14471 Potsdam, Germany
Stefan Kempa
aDepartment of Cell Biology, University of Potsdam, D-14471 Potsdam, Germany
Katrin Hayeß
aDepartment of Cell Biology, University of Potsdam, D-14471 Potsdam, Germany
Dirk Pacholsky
aDepartment of Cell Biology, University of Potsdam, D-14471 Potsdam, Germany
Anu Taivainen
bDepartment of Pathology, Haartman Institute, University of Helsinki, SF-00290 Helsinki, Finland
Rolf Schröder
dDepartment of Neurology, University Hospital Bonn, D-53127 Bonn, Germany
Olli Carpén
bDepartment of Pathology, Haartman Institute, University of Helsinki, SF-00290 Helsinki, Finland
Dieter O. Fürst
aDepartment of Cell Biology, University of Potsdam, D-14471 Potsdam, Germany
Abbreviations used in this paper: GFP, green fluorescent protein; HA, hemagglutinin; Ig, immunoglobulin; LGMD, limb-girdle muscular dystrophy.
Received:
April 18 2000
Revision Requested:
August 01 2000
Accepted:
August 30 2000
Online ISSN: 1540-8140
Print ISSN: 0021-9525
© 2000 The Rockefeller University Press
2000
The Rockefeller University Press
J Cell Biol (2000) 151 (2): 235–248.
Article history
Received:
April 18 2000
Revision Requested:
August 01 2000
Accepted:
August 30 2000
Citation
Peter F.M. van der Ven, Sebastian Wiesner, Paula Salmikangas, Daniel Auerbach, Mirko Himmel, Stefan Kempa, Katrin Hayeß, Dirk Pacholsky, Anu Taivainen, Rolf Schröder, Olli Carpén, Dieter O. Fürst; Indications for a Novel Muscular Dystrophy Pathway: γ-Filamin, the Muscle-Specific Filamin Isoform, Interacts with Myotilin. J Cell Biol 16 October 2000; 151 (2): 235–248. doi: https://doi.org/10.1083/jcb.151.2.235
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement